These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33240287)

  • 1. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During
    Bartlett S; Gemiarto AT; Ngo MD; Sajiir H; Hailu S; Sinha R; Foo CX; Kleynhans L; Tshivhula H; Webber T; Bielefeldt-Ohmann H; West NP; Hiemstra AM; MacDonald CE; Christensen LVV; Schlesinger LS; Walzl G; Rosenkilde MM; Mandrup-Poulsen T; Ronacher K
    Front Immunol; 2020; 11():601534. PubMed ID: 33240287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway.
    Liu J; Ming S; Song W; Meng X; Xiao Q; Wu M; Wu Y; Xie H; Zhou J; Zhong H; Huang X
    Int Immunopharmacol; 2021 Feb; 91():107215. PubMed ID: 33348294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Blunted GPR183/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection.
    Ngo MD; Bartlett S; Bielefeldt-Ohmann H; Foo CX; Sinha R; Arachchige BJ; Reed S; Mandrup-Poulsen T; Rosenkilde MM; Ronacher K
    J Infect Dis; 2022 Jun; 225(12):2219-2228. PubMed ID: 35303091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
    Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
    Front Immunol; 2021; 12():599641. PubMed ID: 33732233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-induced gene 3 (EBI3) polymorphisms and expression are associated with susceptibility to pulmonary tuberculosis.
    Zheng R; Liu H; Song P; Feng Y; Qin L; Huang X; Chen J; Yang H; Liu Z; Cui Z; Hu Z; Ge B
    Tuberculosis (Edinb); 2015 Jul; 95(4):497-504. PubMed ID: 25937126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling tuberculosis pathogenesis through ex vivo lung tissue infection.
    Carranza-Rosales P; Carranza-Torres IE; Guzmán-Delgado NE; Lozano-Garza G; Villarreal-Treviño L; Molina-Torres C; Villarreal JV; Vera-Cabrera L; Castro-Garza J
    Tuberculosis (Edinb); 2017 Dec; 107():126-132. PubMed ID: 29050759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against
    To K; Cao R; Yegiazaryan A; Owens J; Sasaninia K; Vaughn C; Singh M; Truong E; Sathananthan A; Venketaraman V
    Biomol Concepts; 2021 May; 12(1):16-26. PubMed ID: 33966361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.
    Kewcharoenwong C; Saenwongsa W; Willcocks SJ; Bancroft GJ; Fletcher HA; Lertmemongkolchai G
    Tuberculosis (Edinb); 2020 Jul; 123():101939. PubMed ID: 32452426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7
    Huang J; Lee SJ; Kang S; Choi MH; Im DS
    J Pharmacol Exp Ther; 2020 Jul; 374(1):142-150. PubMed ID: 32341017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor receptor bound protein 2-associated binder 2, a scaffolding adaptor protein, negatively regulates host immunity against tuberculosis.
    Hu S; Zhang Y; Yu Y; Jin D; Zhang X; Gu S; Jia H; Chen X; Zhang Z; Jin Q; Ke Y; Liu H
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):575-85. PubMed ID: 24805943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
    Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
    Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity.
    Berod L; Stüve P; Varela F; Behrends J; Swallow M; Kruse F; Krull F; Ghorbani P; Mayer CT; Hölscher C; Sparwasser T
    PLoS One; 2014; 9(7):e102804. PubMed ID: 25050936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.
    Imperiale BR; García A; Minotti A; González Montaner P; Moracho L; Morcillo NS; Palmero DJ; Sasiain MDC; de la Barrera S
    Clin Exp Immunol; 2021 Feb; 203(2):267-280. PubMed ID: 33128773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CISH controls bacterial burden early after infection with Mycobacterium tuberculosis in mice.
    Carow B; Gao Y; Terán G; Yang XO; Dong C; Yoshimura A; Rottenberg ME
    Tuberculosis (Edinb); 2017 Dec; 107():175-180. PubMed ID: 29050767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
    Sathkumara HD; Muruganandah V; Cooper MM; Field MA; Alim MA; Brosch R; Ketheesan N; Govan B; Rush CM; Henning L; Kupz A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20848-20859. PubMed ID: 32778586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
    Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
    Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice.
    Guirado E; Rajaram MV; Chawla A; Daigle J; La Perle KM; Arnett E; Turner J; Schlesinger LS
    Tuberculosis (Edinb); 2018 Jul; 111():170-177. PubMed ID: 30029904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.
    Mayer-Barber KD; Andrade BB; Barber DL; Hieny S; Feng CG; Caspar P; Oland S; Gordon S; Sher A
    Immunity; 2011 Dec; 35(6):1023-34. PubMed ID: 22195750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1 and DLL4 are involved in the human tuberculosis progression and immune response activation.
    Castro RC; Zambuzi FA; Fontanari C; de Morais FR; Bollela VR; Kunkel SL; Schaller MA; Frantz FG
    Tuberculosis (Edinb); 2020 Sep; 124():101980. PubMed ID: 32801053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.